Pre-Implantation Genetic Testing for Aneuploidy (PGT-A), formerly known as Pre-Implantation Genetic Screening (PGS) can be combined with IVF treatment to detect chromosomal abnormalities in embryos. It is often recommended for specific patient groups who are at higher risk of miscarriage or have had recurring unsuccessful IVF cycles.
In Vitro Fertilisation (IVF) In Vitro Fertilisation (IVF)
Pre-Implantation Genetic Testing for Aneuploidy (PGT-A)
IVF with NGS Screening

What is PGT-A?


Advantages of IVF with PGT-A

IVF with NGS Screening

Over the last 30 years, IVI has helped more than 250,000 dreams come true.


97% of our patients recommend IVI. We’re with you at every stage of your treatment, providing support and care.


IVI has a worldwide reputation for innovative research and has developed and patented pioneering techniques and technologies.


IVI is one of the largest fertility treatment providers in the world, with more than 75 clinics in 9 countries.


If PGT-A is recommended for your specific case, it will be explained in detail by your IVI consultant during your first consultation. You will then be able to make an informed decision before you begin your treatment cycle. IVF treatment with PGT-A will resemble the following pathway:

Ovarian Stimulation

Ovarian stimulation

Oocyte retrieval

egg collection


The process of fertilisation takes place in the laboratory. The insemination can be performed via conventional IVF, which involves placing an oocyte surrounded by spermatozoa in a culture plate, or via an intracytoplasmic sperm injection (ICSI), which involves depositing a live spermatozoon directly into the oocyte using a pipette. ICSI is only recommended in specific cases, and your consultant will explain this in detail if this is advised.

Embryo culture and PGT-A

Embryo culture and PGT-A

Embryo transfer

Embryo transfer
In Vitro Fertilisation (IVF)

Freezing additional embryos

Back to toparrow_drop_up